CDIXOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Cardiff Lexington Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.04−0.01 (-25.53%)
Close on Oct 19, 2026
- Market cap
- $534.29K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$4.8250 (−99.28%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Cardiff Lexington Corp grew revenue 0.3% to $10.21M over the twelve months to Jun 30, 2026. Operating income fell 223.1% to -$1.11M, moving the operating margin from 8.8% to -10.9%.
Revenue
$10.21M
+0.3% vs. a year earlier
Operating income
-$1.11M
-223.1% vs. a year earlier
EPS, diluted
-$0.80
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $534.29K
- P/E ratio
- –
- Price to sales
- 0.05
- Price to book
- 0.30
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $10.21M
- Net income
- -$9.40M
- EPS, diluted
- -$0.80
- Book value per share
- $0.11
- Diluted shares
- 15M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$10.21M+0.3% YoY
Gross profit
$6.17M+4.4% YoY
Operating income
-$1.11M-223.1% YoY
Net income
-$9.40M
EPS, diluted
-$0.80
Free cash flow
–
Reported periodTrailing twelve months